We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
YPF Sociedad Anonima (YPF) - free report >>
ADMA Biologics Inc (ADMA) - free report >>
Ekso Bionics Holdings, Inc. (EKSO) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 31st
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
ADMA Biologics, Inc. (ADMA - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
ADMA Biologics Inc Price and Consensus
ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote
Inhibikase Therapeutics, Inc. (IKT - Free Report) : This clinical-stage pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 16% over the last 60 days.
Inhibikase Therapeutics, Inc. Price and Consensus
Inhibikase Therapeutics, Inc. price-consensus-chart | Inhibikase Therapeutics, Inc. Quote
YPF Sociedad Anónima (YPF - Free Report) : This international energy company engaging in the integrated business of hydrocarbons has seen the Zacks Consensus Estimate for its current year earnings increasing 24.2% over the last 60 days.
YPF Sociedad Anonima Price and Consensus
YPF Sociedad Anonima price-consensus-chart | YPF Sociedad Anonima Quote
Anavex Life Sciences Corp. (AVXL - Free Report) : This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.
Anavex Life Sciences Corp. Price and Consensus
Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote
Ekso Bionics Holdings, Inc. (EKSO - Free Report) : This exoskeleton products company has seen the Zacks Consensus Estimate for its current year earnings increasing 25.6% over the last 60 days.
Ekso Bionics Holdings, Inc. Price and Consensus
Ekso Bionics Holdings, Inc. price-consensus-chart | Ekso Bionics Holdings, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.